Literature DB >> 23183635

Past, present, and future of radiotherapy for the benefit of patients.

Juliette Thariat1, Jean-Michel Hannoun-Levi, Arthur Sun Myint, Te Vuong, Jean-Pierre Gérard.   

Abstract

Radiotherapy has been driven by constant technological advances since the discovery of X-rays in 1895. Radiotherapy aims to sculpt the optimal isodose on the tumour volume while sparing normal tissues. The benefits are threefold: patient cure, organ preservation and cost-efficiency. The efficacy and tolerance of radiotherapy were demonstrated by randomized trials in many different types of cancer (including breast, prostate and rectum) with a high level of scientific evidence. Such achievements, of major importance for the quality of life of patients, have been fostered during the past decade by linear accelerators with computer-assisted technology. More recently, these developments were augmented by proton and particle beam radiotherapy, usually combined with surgery and medical treatment in a multidisciplinary and personalized strategy against cancer. This article reviews the timeline of 100 years of radiotherapy with a focus on breakthroughs in the physics of radiotherapy and technology during the past two decades, and the associated clinical benefits.

Entities:  

Mesh:

Year:  2012        PMID: 23183635     DOI: 10.1038/nrclinonc.2012.203

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  99 in total

Review 1.  Current ICRU definitions of volumes: limitations and future directions.

Authors:  James A Purdy
Journal:  Semin Radiat Oncol       Date:  2004-01       Impact factor: 5.934

Review 2.  [Cyberknife robotic stereotactic radiotherapy: technical aspects and recent developments].

Authors:  J Thariat; S Marcié; P-Y Marcy; R Trimaud; G Angellier; H Mammar; P-Y Bondiau; J-P Gerard
Journal:  Bull Cancer       Date:  2010-07       Impact factor: 1.276

Review 3.  Image-guided radiation therapy for muscle-invasive bladder cancer.

Authors:  Juliette Thariat; Shafak Aluwini; Qiong Pan; Mickael Caullery; Pierre-Yves Marcy; Martin Housset; Jean-Leon Lagrange
Journal:  Nat Rev Urol       Date:  2011-11-08       Impact factor: 14.432

4.  1000 Curie cobalt units for radiation therapy. I. The Saskatchewan cobalt 60 unit.

Authors:  H E JOHNS; L M BATES; T A WATSON
Journal:  Br J Radiol       Date:  1952-06       Impact factor: 3.039

5.  Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.

Authors:  Juanita Mary Crook; Alfonso Gomez-Iturriaga; Kris Wallace; Clement Ma; Sharon Fung; Shabbir Alibhai; Michael Jewett; Neil Fleshner
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

6.  70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

Authors:  Véronique Beckendorf; Stéphane Guerif; Elisabeth Le Prisé; Jean-Marc Cosset; Agnes Bougnoux; Bruno Chauvet; Naji Salem; Olivier Chapet; Sylvain Bourdain; Jean-Marc Bachaud; Philippe Maingon; Jean-Michel Hannoun-Levi; Luc Malissard; Jean-Marc Simon; Pascal Pommier; Men Hay; Bernard Dubray; Jean-Léon Lagrange; Elisabeth Luporsi; Pierre Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

7.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

8.  [Volume and costs of the hospital management of cancer in France in 1999].

Authors:  Laurent Borella; Stéphane Finkel; Nicolas Crapeau; Patrick Peuvrel; Martine Sauvage; Lionel Perrier; Eric Lepage; Jean Villeminot; Bernard Garrigues
Journal:  Bull Cancer       Date:  2002-09       Impact factor: 1.276

9.  Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial.

Authors: 
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

Review 10.  Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.

Authors:  Jimm Grimm; Tamara LaCouture; Raymond Croce; Inhwan Yeo; Yunping Zhu; Jinyu Xue
Journal:  J Appl Clin Med Phys       Date:  2011-02-08       Impact factor: 2.243

View more
  79 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation.

Authors:  Anne-Catherine Wéra; Alison Lobbens; Miroslav Stoyanov; Stéphane Lucas; Carine Michiels
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

Review 3.  The evolution of cancer surgery and future perspectives.

Authors:  Lynda Wyld; Riccardo A Audisio; Graeme J Poston
Journal:  Nat Rev Clin Oncol       Date:  2014-11-11       Impact factor: 66.675

Review 4.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 5.  Why should radiation oncology do translational research? [corrected].

Authors:  Rut Cañas; Isabel Linares; Ferran Guedea; Miguel Ángel Berenguer
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-12

6.  Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.

Authors:  Hee Chul Park; Jeong Il Yu; Jason Chia-Hsien Cheng; Zhao Chong Zeng; Ji Hong Hong; Michael Lian Chek Wang; Mi Sook Kim; Kwan Hwa Chi; Po-Ching Liang; Rheun-Chuan Lee; Wan-Yee Lau; Kwang Hyub Han; Pierce Kah-Hoe Chow; Jinsil Seong
Journal:  Liver Cancer       Date:  2016-05-03       Impact factor: 11.740

7.  Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.

Authors:  Sean P Dineen; Christina L Roland; Rachel Feig; Caitlin May; Shouhao Zhou; Elizabeth Demicco; Ghadah Al Sannaa; Davis Ingram; Wei-Lein Wang; Vinod Ravi; Ashleigh Guadagnolo; Dina Lev; Raphael E Pollock; Kelly Hunt; Janice Cormier; Alex Lazar; Barry Feig; Keila E Torres
Journal:  Ann Surg Oncol       Date:  2015-03-06       Impact factor: 5.344

Review 8.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

9.  Photon, light ion, and heavy ion cancer radiotherapy: paths from physics and biology to clinical practice.

Authors:  Jac A Nickoloff
Journal:  Ann Transl Med       Date:  2015-12

Review 10.  Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Authors:  Andrei Laszlo; Dinesh Thotala; Dennis E Hallahan
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.